Back to Search
Start Over
SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based study.
- Source :
-
Microbiology spectrum [Microbiol Spectr] 2024 Jun 04; Vol. 12 (6), pp. e0012624. Date of Electronic Publication: 2024 Apr 30. - Publication Year :
- 2024
-
Abstract
- With the emergence of highly transmissible variants of concern, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still poses a global threat of coronavirus disease 2019 (COVID-19) resurgence. Cellular responses to novel variants are more robustly maintained than humoral responses, and therefore, cellular responses are of interest in assessing immune protection against severe disease in the population. We aimed to assess cellular responses to SARS-CoV-2 at the population level. IFN <subscript>γ</subscript> (interferon <subscript>γ</subscript> ) responses to wild-type SARS-CoV-2 were analyzed using an ELISpot assay in vaccine-naive individuals with different humoral responses: Ig (IgM and/or IgG) seronegative ( n = 90) and seropositive ( n = 181) with low (<300 U/mL) or high (≥300 U/mL) humoral responses to the spike receptor binding domain (anti-S-RBD). Among the seropositive participants, 71.3% (129/181) were IFN <subscript>γ</subscript> ELISpot positive, compared to 15.6% (14/90) among the seronegative participants. Common COVID-19 symptoms such as fever and ageusia were associated with IFN <subscript>γ</subscript> ELISpot positivity in seropositive participants, whereas no participant characteristics were associated with IFN <subscript>γ</subscript> ELISpot positivity in seronegative participants. Fever and/or dyspnea and anti-S-RBD levels were associated with higher IFN <subscript>γ</subscript> responses. Symptoms of more severe disease and higher anti-S-RBD responses were associated with higher IFN <subscript>γ</subscript> responses. A significant proportion (15.6%) of seronegative participants had a positive IFN <subscript>γ</subscript> ELISpot. Assessment of cellular responses may improve estimates of the immune response to SARS-CoV-2 in the general population.<br />Importance: Data on adaptive cellular immunity are of interest to define immune protection against severe acute respiratory syndrome coronavirus 2 in a population, which is important for decision-making on booster-vaccination strategies. This study provides data on associations between participant characteristics and cellular immune responses in vaccine-naive individuals with different humoral responses.<br />Competing Interests: The authors declare no conflict of interest.
- Subjects :
- Humans
Netherlands epidemiology
Male
Female
Cross-Sectional Studies
Adult
Middle Aged
Immunoglobulin G blood
Immunoglobulin G immunology
Aged
Young Adult
Immunoglobulin M blood
COVID-19 Vaccines immunology
COVID-19 Vaccines administration & dosage
Spike Glycoprotein, Coronavirus immunology
Enzyme-Linked Immunospot Assay
COVID-19 immunology
COVID-19 prevention & control
SARS-CoV-2 immunology
Immunity, Humoral
Antibodies, Viral blood
Antibodies, Viral immunology
Immunity, Cellular
Interferon-gamma immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2165-0497
- Volume :
- 12
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Microbiology spectrum
- Publication Type :
- Academic Journal
- Accession number :
- 38686954
- Full Text :
- https://doi.org/10.1128/spectrum.00126-24